Showing results (1-10 of 743) with videos related to
Sort By:
Pageof 75
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
Effect of drugs in secondary disease progression in patients with multiple sclerosisLudwig KapposInternational MS Journal|July 29, 2004
Neuroprotection in multiple sclerosis report from the MS Forum 16th Modern Management Workshop, March 2004, Cernobbio, ItalyReinhard Hohlfeld, Ludwig KapposHandbook of Clinical Neurology|February 11, 2014
Clinical trials in multiple sclerosisGary Cutter, Ludwig KapposTherapeutic Advances in Neurological Disorders|May 20, 2020
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSERalf Gold, Douglas L Arnold, Amit Bar-Or, et al.Neurodegenerative Disease Management|November 28, 2015
What is new in MS spasticity research? Poster session highlightsLudwig Kappos, Franz FazekasNeuro-Degenerative Diseases|December 14, 2007
Natalizumab: targeting alpha4-integrins in multiple sclerosisBritta Engelhardt, Ludwig KapposInternational MS Journal|February 24, 2004
Vancouver Consortium of MS Centers' Magnetic Resonance Imaging GuidelinesErnst-Wilhelm Radue, Ludwig KapposJournal of the Neurological Sciences|April 22, 2006
Retraining attention in MSIris-Katharina Penner, Ludwig KapposClinical Therapeutics|November 4, 2015
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III StudiesGavin Giovannoni, Ralf Gold, Robert J Fox, et al.Current Neurology and Neuroscience Reports|July 27, 2011
Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directionsMatthias Mehling, Ludwig Kappos, Tobias DerfussPageof 75